Actively Recruiting
Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.
Led by Australian Catholic University · Updated on 2025-05-23
156
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
Sponsors
A
Australian Catholic University
Lead Sponsor
A
Abbott Diabetes Care
Collaborating Sponsor
AI-Summary
What this Trial Is About
A parallel, single-blinded, randomised clinical trial conducted remotely across Australia from the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with type 2 diabetes, by researchers from Australian Catholic University, University of Adelaide, University of Queensland, University of Wollongong, Monash University, Monash Partners, Deakin University, La Trobe University and Melbourne University.
CONDITIONS
Official Title
Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Living anywhere in Australia with a postal address
- Diagnosed with type 2 diabetes by a GP or endocrinologist
- Current HbA1c level of 7.0% or higher
- Have a smartphone and able to use it independently
You will not qualify if you...
- Under 18 years of age
- Using insulin therapy within the last three months or medications affecting blood glucose (e.g., steroids)
- Used continuous glucose monitoring within the last six months
- High score on Eating Disorder Examination Questionnaire (EDE-Q) indicating eating disorder risk
- Currently or recently (within three months) consulting with an Accredited Practicing Dietitian
- Not weight stable (more than 5 kg change in last three months)
- Experienced severe hypoglycaemic event requiring assistance in last six months
- Changed antihyperglycaemic medications within last three months
- Pregnant or breastfeeding within 24 weeks
- History of psychotic or major psychiatric disorders
- History of blood disorders affecting HbA1c outcomes (e.g., anemia, thalassemia)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Australian Catholic University
Melbourne, Victoria, Australia, 3065
Actively Recruiting
Research Team
E
Evelyn B Parr, PhD
CONTACT
K
Katherine Roberts-Thomson, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here